What is important to target fibrosis: Location, location, location! of cold-shock proteins

International Urology and Nephrology

Volumn 43, Issue 2, 2011, Pages 589-591

  Pabst, Melanie ^a   Mertens, Peter R ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CHEMICAL COMPOUND; COLD SHOCK PROTEIN; COLLAGEN; COLLAGEN TYPE 1; HSC 025; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; Y BOX BINDING PROTEIN 1;

CHRONIC INFLAMMATION; COLLAGEN SYNTHESIS; CYTOPLASM; DRUG TARGETING; FIBROGENESIS; FIBROSIS; GENE EXPRESSION; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN SECRETION; SCAR FORMATION; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; COLD SHOCK PROTEINS AND PEPTIDES; FIBROSIS; HUMANS; KIDNEY; Y-BOX-BINDING PROTEIN 1;

EID: 79959735923     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-011-9925-x     Document Type: Short Survey

References (13)

1. Higashi K, Inagaki Y, Suzuki N et al (2003) Y-box-binding protein YB-1 mediates transcriptional repression of human α2(I) collagen gene expression by Interferon-γ. J Biol Chem 278(7):5156-5162 (Pubitemid 36801027)
2. Higashi K, Inagaki Y, Fujimori K et al (2003) Interferon-γ interferes with transforming growth factor-β signaling through direct interaction of YB-1 with Smad3. J Biol Chem 278(44):43470-43479 (Pubitemid 37345970)
3. Wynn TA (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117(3):524-529
4. Inagaki Y, Okazaki I (2007) Emerging insights into transforming growth factor β Smad signal in hepatic fibrogenesis. Gut 56:284-292
5. Baroni GS, D'Ambrosio L, Curto P et al (1996) Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 23:1189-1899
6. Matsumoto K, Nakamura T (2001) Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int 59(6):2023-2038 (Pubitemid 32467594)
7. Weng HL, Wang BE, Jia JD et al (2005) Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: a randomized controlled study. Clin Gastroenterol Hepatol 3(8):819-828
8. Dooley S, Hamzavi J, Ciuclan L et al (2008) Hepatocytespecific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology 135(2):642-659
9. Inagaki Y, Kushida M, Higashi K et al (2005) Cell typespecific intervention of transforming growth factor β/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice. Gastroenterology 129:259-268 (Pubitemid 41002059)
10. Dooley S, Said HM, Gressner AM et al (2006) Y-box protein-1 is the crucial mediator of antifibrotic interferon-γ effects. J Biol Chem 281(3):1784-1795
11. Hasegawa M, Matsushita Y, Horikawa M et al (2009) A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis. Arthritis Rheum 60(11):3465-3475
12. van Roeyen CR, Eitner F, Martinkus S et al (2005) Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease. J Am Soc Nephrol 16(10):2985-2996 (Pubitemid 44743496)
13. Norman JT, Lindahl GE, Shakib K et al (2001) The Y-box binding protein YB-1 suppresses collagen α1(I) gene transcription via an evolutionarily conserved regulatory element in the proximal promoter. J Biol Chem 276(32):29880-29890